CELL DISCOV 润色咨询

Cell Discovery

出版年份：暂无数据 年文章数：199 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：0.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2021-11-18 121f392fm08(暂无昵称)

    第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。

    9

    展开9条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2021-03-23 zyn930812

    最近有人投稿吗？under consideration 9天了……音信全无

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2022-04-25 dgdgdgygygyg

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2022-05-14 ms4000000787672752

    审稿速度:3.0
    经验分享：underconsideration 已经两个月了

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2018-09-03 ms4591412325009157

    这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2022-03-12 ms8000000043577878

    投稿14天，才收到通知没有外审。不是很快啊。

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2021-04-29 ms5000002143658131

    作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2021-05-03 ms5000002143658131

    听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2022-05-20 dgdgdgygygyg

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1071385, encodeId=bab910e13855e, content=第一天投稿，第二天分配编辑，第三天就under consideration，然后两周没动静，谁知到这是审还是没审啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47e42294781, createdName=121f392fm08(暂无昵称), createdTime=Thu Nov 18 12:32:02 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950324, encodeId=ce59950324ce, content=最近有人投稿吗？under consideration 9天了……音信全无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80135179168, createdName=zyn930812, createdTime=Tue Mar 23 12:17:16 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214085, encodeId=f342121408525, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：看了一下大家对于CR和CD两本国产强刊的意见，感觉很不友好。这两本杂志势必会成为国产生物医学领域期刊的旗舰，可能以后评论区的大家可能没几个人能发的上去了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Mon Apr 25 12:47:56 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219617, encodeId=4642121961e65, content=审稿速度:3.0<br>经验分享：underconsideration 已经两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cacb8111229, createdName=ms4000000787672752, createdTime=Sat May 14 18:08:52 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846934, encodeId=05498469347a, content=这个杂志b格还不小啊，投过去直接拒稿，不过后来被6分的老牌杂志接受了。不看好这个杂志，给人印象很差 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Mon Sep 03 19:52:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202065, encodeId=0113120206583, content=投稿14天，才收到通知没有外审。不是很快啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35da6511629, createdName=ms8000000043577878, createdTime=Sat Mar 12 20:49:19 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961441, encodeId=2f8b96144121, content=作为业内人士，建议不要投这个杂志，每年发文量只有30多篇，投稿的都几千。国产杂志关系户很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Thu Apr 29 08:43:12 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962402, encodeId=6ac6962402e9, content=听好多人说这个杂志认可度不是很好，上面的文章争议挺大的。国外就更不怎么认可了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c6b5488752, createdName=ms5000002143658131, createdTime=Mon May 03 08:47:40 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221088, encodeId=d08412210887e, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：nature旗下的杂志通讯邮箱（投稿用的通讯邮箱）绑定research square，可以看到极其详细的投稿状态。包括邀请了几个审稿人，几个审稿人同意，几个审稿人返回意见等等，你们都不知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Fri May 20 06:17:17 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229146, encodeId=bbf61229146ea, content=审稿速度:2.0 | 投稿命中率:5.0<br>经验分享：新的IF出来了，38.079分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/18/56186736f4d1be1601744995196f2ab0.jpg, createdBy=a3d41955761, createdName=dgdgdgygygyg, createdTime=Tue Jun 28 13:58:54 CST 2022, time=2022-06-28, status=1, ipAttribution=)]
    2022-06-28 dgdgdgygygyg

    审稿速度:2.0 | 投稿命中率:5.0
    经验分享：新的IF出来了，38.079分。

    3

    展开3条回复
共147条页码: 1/15页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分